Veraxa Biotech AG (NASDAQ:VRXAW) Stock Price & Analysis

–

USD

–(–)

Open

$0.149

Prev. Close

$0.101

High

$0.149

Low

$0.14

Company Profile

Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. [9] The company is advancing a drug discovery and development engine for ADCs and other novel antibody-based therapy concepts. [14] It was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL). [8, 14]

CEOChristoph Antz

SectorHealthcare

IndustryBiotechnology

Employees47

IPO DateJun 10, 2026

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

AddressIm Neuenheimer Feld 584

City / State / ZIPHeidelberg, ZH, 69120

CountryGermany

Websitehttps://www.veraxa.com

Veraxa Biotech AG

Company Profile

Recently from Cashu